UPEXI, INC. (UPXI) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US39959A2050
UPEXI, INC. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 15.81 m USD | 25.00 m USD |
| Gross profit | 10.87 m USD | 22.37 m USD |
| Operating income | -12.50 m USD | -240.85 m USD |
| EBIT | -13.58 m USD | -246.00 m USD |
| Net income | -13.68 m USD | -246.06 m USD |
| Diluted EPS – continuing operations | -1.73 USD | -3.87 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About UPEXI, INC.
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; and functional mushrooms under the Cure Mushrooms brand. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.
More stocks
- Daily Polymer (4716.TWO)
- Touchstone Exploration Inc (TXP.TO)
- Anfield Resources Inc (AEC.V)
- SEMICO CAPITAL BERHAD (0388.KL)
- Sinil Pharmaceutical Co. Ltd (012790.KQ)
- Company K Partners Limited (307930.KQ)
- Cardiff Oncology, Inc. (CRDF)
- ALUX Co., Ltd. (475580.KQ)
- Nordwest Handel AG (NWX.F)
- SYNergy ScienTech Corp (6558.TW)
- DIVA Laboratories Ltd (4153.TWO)
- Titanium Oyj (TITAN.HE)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.